Pharma scores poorly in ‘environment’ in ESG ratings Korea Biomedical ReviewPharma scores poorly in ‘environment’ in ESG ratings Korea Biomedical ReviewPharma scores poorly in ‘environment’ in ESG ratings Korea Biomedical Review
Impact Investing Forum 2025
https://impactinvestingconferences.com/
London UK. May 14-15, 2025.